Table 2.
Baseline physical examination.
| Index | EPIAO® (N = 99) | EPREX® (N = 101) | Statistics | P value |
|---|---|---|---|---|
| Abdomen, n (%) | ||||
| Abnormality had no clinical significance | 6 (6.12) | 6 (6.00) | - | >.99 |
| Normal | 92 (93.88) | 94 (94.00) | ||
| ENT, n (%) | ||||
| Abnormality had no clinical significance | 1 (1.09) | 0 (0.00) | - | >.99 |
| Normal | 91 (98.91) | 100 (100.00) | ||
| Limbs, n (%) | ||||
| Abnormality had no clinical significance | 1 (1.02) | 3 (3.00) | - | >.99 |
| Normal | 97 (98.98) | 97 (97.00) | ||
| General appearance, n (%) | ||||
| Abnormality had no clinical significance | 1 (1.02) | 1 (1.00) | - | >.99 |
| Normal | 97 (98.98) | 99 (99.00) | ||
| Head and neck, n (%) | ||||
| Abnormality had no clinical significance | 1 (1.02) | 1 (1.00) | - | >.99 |
| Normal | 97 (98.98) | 99 (99.00) | ||
| Heart, n (%) | ||||
| Abnormality had no clinical significance | 29 (29.59) | 25 (25.00) | 0.5261 | .46 |
| Normal | 69 (70.41) | 75 (75.00) | ||
| Lungs, n (%) | ||||
| Abnormality had no clinical significance | 12 (12.24) | 10 (10.00) | 0.2526 | .61 |
| Normal | 86 (87.76) | 90 (90.00) | ||
| Lymph nodes, n (%) | ||||
| Abnormality had no clinical significance | 0 (0) | 0 (0) | - | >.99 |
| Normal | 98 (100) | 100 (100) | ||
| Muscles and bones, n (%) | ||||
| Abnormality had no clinical significance | 1 (1.02) | 3 (3.00) | - | >.99 |
| Normal | 97 (98.98) | 97 (97.00) | ||
| Nervous system, n (%) | ||||
| Abnormality had no clinical significance | 1 (1.02) | 3 (3.00) | - | >.99 |
| Normal | 97 (98.98) | 97 (97.00) | ||
| Skin, n (%) | ||||
| Abnormality had no clinical significance | 14 (14.29) | 14 (14.00) | 0.0033 | .95 |
| Normal | 84 (85.71) | 86 (86.00) |